Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients

References

• Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W., Brown R. H Jr. Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Annals of Neurology 1997; 42: 644–54
   PubMed Web of Science ®Google Scholar
• Bergeron C. Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1995; 129((Suppl))81–4
   PubMedGoogle Scholar
• Bertel O., Malessa S., Sluga E., Hornykiewicz O. Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Research 1991; 566: 54–60
   PubMed Web of Science ®Google Scholar
• Boullerne A. I., Petry K. G., Meynard M., Geffard M. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S‐nitrosocysteine. Journal Of Neuroimmunology 1995; 60: 117–24
   PubMed Web of Science ®Google Scholar
• Chou S. M., Han C. Y., Wang H. S., Vlassara H., Bucala R. A receptor for advanced glycosylation end‐products (AGEs) is colocalized with neurofilament‐bound AGEs and SOD1 in motor neurons of ALS: immunohistochemical study. Journal of The Neurological Sciences 1999; 169: 87–92
   PubMed Web of Science ®Google Scholar
• Clark F., Proudfit H. The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry. Brain Research 1991; 538: 231–45
   PubMed Web of Science ®Google Scholar
• Clark F., Proudfit H. The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry. Brain Research 1991; 547: 279–88
   PubMed Web of Science ®Google Scholar
• Colom L. V., Alexianu M. E., Mosier D. R., Smith R. G., Appel S. H. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motor neuron cell line. Experimental Neurology 1997; 146: 354–60
   PubMed Web of Science ®Google Scholar
• Colton C. A., Gilbert D. L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Letters 1987; 223: 284–8
   PubMed Web of Science ®Google Scholar
• Daverat P., Geffard M., Orgogozo J. M. Identification and characterization of anti‐conjugated azelaic acid antibodies in multiple sclerosis. Journal of Neuroimmunology 1989; 22: 129–34
   PubMed Web of Science ®Google Scholar
• Drukarch B., van Muiswinkel F. L. Drug treatment of Parkinson's disease. Time for phase II. Biochemical Pharmacology 2000; 59: 1023–31
   PubMed Web of Science ®Google Scholar
• Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. Journal of Neurochemistry 1997; 69: 2064–74
   PubMed Web of Science ®Google Scholar
• Fornstedt B., Bergh I., Rosengren E., Carlsson A. An improved HPLC‐electrochemical detection method for measuring brain levels of 5‐S‐cysteinyldopamine, 5‐S‐cysteinyl‐3,4‐dihydroxyphenylalanine, and 5‐S‐cysteinyl‐3,4‐dihydroxyphenylacetic acid. Journal of Neurochemistry 1990; 54: 578–86
   PubMed Web of Science ®Google Scholar
• Fornstedt B., Rosengren E., Carlsson A. Occurrence and distribution of 5‐S‐cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 1986; 25: 451–4
   PubMed Web of Science ®Google Scholar
• Fratantoni S., Weisz G., Pardal A., Reisin R., Uchitel O. Amyotrophic lateral sclerosis IgG‐treated neuromuscular junctions develop sensitivity to L‐type calcium channel blocker. Muscle Nerve 2000; 23: 543–50
   PubMed Web of Science ®Google Scholar
• Geffard M., Bodet D., Claudepierre P., Metzger J., Sibilia J. Circulating antibodies directed against NO‐modified self antigens in chronic neurological and rheumatismal diseases. Immunoanalyse & Biologie Specialisee 1998; 13: 209–17
   Google Scholar
• Geffard M., Bodet D., Dabadie M. P., Arnould L. Identification of antibodies in sera of breast cancer patients. Immuno‐analyse & Biologie Specialisee 2003; 18: 248–53
   Google Scholar
• Geffard M., Bodet D., Martinet Y., Dabadie M. ‐. P. Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: interest and perspectives. Immunoanalyse & Biologie Specialisee 2002; 17: 302–10
   Google Scholar
• Gelinas S., Chapados C., Beauregard M., Gosselin I., Martinoli M. G. Effect of oxidative stress on stability and structure of neurofilament proteins. Biochemistry and Cell Biology 2000; 78: 667–74
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry 1992; 59: 1609–23
   PubMed Web of Science ®Google Scholar
• Hastings T. G., Zigmond M. J. Identification of catechol‐protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione. Journal of Neurochemistry 1994; 63: 1126–32
   PubMed Web of Science ®Google Scholar
• Heath P. R., Shaw P. J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26: 438–58
   PubMed Web of Science ®Google Scholar
• Holstege J., Kuypers H. Brainstem projections to spinal motor neurons: an update. Neuroscience 1987; 23: 809–21
   PubMed Web of Science ®Google Scholar
• Ito S., Fujita K. Conjugation of dopa and 5‐S‐cysteinyldopa with cysteine mediated by superoxide radical. Biochemical Pharmacology 1982; 31: 2887–9
   PubMed Web of Science ®Google Scholar
• Klegeris A., McGeer P. L. Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants. Journal of Neuroimmunology 1994; 53: 83–90
   PubMed Web of Science ®Google Scholar
• LaVoie M. J., Hastings T. G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. The Journal of Neuroscience 1999; 19: 1484–91
   PubMed Web of Science ®Google Scholar
• LaVoie M. J., Hastings T. G. Peroxynitrite‐ and nitrite‐induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. Journal of Neurochemistry 1999; 73: 2546–54
   PubMed Web of Science ®Google Scholar
• Leanza G., Maccavino M. C., Stanzani S. Noradrenergic neurotransmission in the ventral spinal cord: basic characteristics and effects of denervating lesions, as studied in the awake rat by microdialysis. Brain Research 1996; 738: 281–91
   PubMed Web of Science ®Google Scholar
• Llinas R., Sugimori M., Cherksey B., Smith R., Delbono O., Stefani E., Appel S. IgG from amyotrophic lateral sclerosis patients increases current through P‐type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci. USA 1993; 90: 11743–7
   PubMed Web of Science ®Google Scholar
• Manabe Y., Wang J., Murakami T., Warita H., YHayashi T., Shoji M., Abe K. Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite. Journal of Neuroscience Research 2001; 65: 371–7
   PubMed Web of Science ®Google Scholar
• Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., et al. Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Annals of Neurology 1998; 44: 819–24
   PubMed Web of Science ®Google Scholar
• Pioro E. P. Antioxidant therapy in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication Of The World Federation Of Neurology, Research Group on Motor Neuron Diseases 2000; 1: 5–12, discussion 13–5
   PubMed Web of Science ®Google Scholar
• Przedborski S., Dhawan V., Donaldson D., Murphy, McKenna‐Yasek D., Mandel F., et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations. Neurology 1996; 47: 1546–51
   PubMed Web of Science ®Google Scholar
• Rakhit R., Cunningham P., Furtos‐Matei A., Dahan S., Qi X. ‐. F., Crow J. P., et al. Oxidation‐induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. The Journal of Biological Chemistry 2002; 277: 47551–6
   PubMed Web of Science ®Google Scholar
• Shen X. M., Dryhurst G. Further insights into the influence of L‐cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. Chemical Research in Toxicology 1996; 9: 751–63
   PubMed Web of Science ®Google Scholar
• Shen X. M., Xia B., Wrona M. Z., Dryhurst G. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N‐acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson s disease. Chemical Research in Toxicology, 9: 1117–26
   PubMed Web of Science ®Google Scholar
• Sidell K. R., Olson S. J., Ou J. J., Zhang Y., Amarnath V., Montine T. J. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. Journal of Neurochemistry 2001; 79: 510–21
   PubMed Web of Science ®Google Scholar
• Takahashi H., Snow B., Bhatt M. H., Peppard R., Eisen A., Calne D. B. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 1993; 342: 1016–8
   PubMed Web of Science ®Google Scholar
• Trotti D., Rizzini B. L., Rossi D., Haugeto O., Racagni G., Danbolt N. C., Volterra A. Neuronal and glial glutamate transporters possess an SH‐based redox regulatory mechanism. The European Journal Of Neuroscience 1997; 9: 1236–43
   PubMed Web of Science ®Google Scholar
• Tse D. C., McCreery R. L., Adams R. N. Potential oxidative pathways of brain catecholamines. Journal of Medicinal Chemistry 1976; 19: 37–40
   PubMed Web of Science ®Google Scholar
• Valentine J. S., Hart P. J. Misfolded Cu/Zn SOD and amyotrophic lateral sclerosis. Proceedings of The National Academy of Sciences of The United States of America 2003; 100: 3617–22
   PubMed Web of Science ®Google Scholar
• Vogels O. J. M., Veltman J., Oyen W. J. G., Horstink M. W. I. M. Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down‐regulation versus striatal cell degeneration. Journal of Neurological Sciences 2000; 180: 62–5
   PubMed Web of Science ®Google Scholar
• Whitehead R. E., Ferrer J. V., Javitch J. A., Justice J. B. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. Journal of Neurochemistry 2001; 76: 1242–51
   PubMed Web of Science ®Google Scholar
• Xia X. G., Schmidt N., Teismann P., Ferger B., Schulz J. B. Dopamine mediates striatal malonate toxicity via dopamine transporter‐dependent generation of reactive oxygen species and D2 but not D1 receptor activation. Journal of Neurochemistry 2001; 79: 63–70
   PubMed Web of Science ®Google Scholar
• Xin W., Shen W., Dryhurst G. Oxidative metabolites of 5‐S‐cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha‐ketoglutamate dehydrogenase and pyruvate dehydrogenase complexes: possible implications for neurodegenerative brain disorders. Chemical Research in Toxicology 2000; 13: 749–60
   PubMed Web of Science ®Google Scholar
• Zhang J., Kravtsov V., Amarnath V., Picklo M., Graham D., Montine T. Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. Journal of Neurochemistry 2000; 74: 970–8
   PubMed Web of Science ®Google Scholar
• Zhang H., Andrekopoulos C., Joseph J., Crow J., Kalyanaraman B. The carbonate radical anion‐induced covalent aggregation of human cooper, zinc superoxide dismutase, and alpha‐synuclein: intermediacy of tryptophan‐ and tyrosine‐derived oxidation products. Free Radic Biol Med 2004; 36: 1355–65
   PubMed Web of Science ®Google Scholar